Global Celecoxib API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Celecoxib API market size was valued at USD 58 million in 2023 and is forecast to a readjusted size of USD 79 million by 2030 with a CAGR of 4.7% during review period.
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.
The Global Info Research report includes an overview of the development of the Celecoxib API industry chain, the market status of Pharmaceutical (Standard grade Celecoxib API, Micronized Celecoxib API), Laboratory (Standard grade Celecoxib API, Micronized Celecoxib API), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Celecoxib API.
Regionally, the report analyzes the Celecoxib API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Celecoxib API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Celecoxib API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Celecoxib API industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Standard grade Celecoxib API, Micronized Celecoxib API).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Celecoxib API market.
Regional Analysis: The report involves examining the Celecoxib API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Celecoxib API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Celecoxib API:
Company Analysis: Report covers individual Celecoxib API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Celecoxib API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Laboratory).
Technology Analysis: Report covers specific technologies relevant to Celecoxib API. It assesses the current state, advancements, and potential future developments in Celecoxib API areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Celecoxib API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Celecoxib API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Celecoxib API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celecoxib API, with price, sales, revenue and global market share of Celecoxib API from 2019 to 2024.
Chapter 3, the Celecoxib API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celecoxib API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Celecoxib API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celecoxib API.
Chapter 14 and 15, to describe Celecoxib API sales channel, distributors, customers, research findings and conclusion.
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.
The Global Info Research report includes an overview of the development of the Celecoxib API industry chain, the market status of Pharmaceutical (Standard grade Celecoxib API, Micronized Celecoxib API), Laboratory (Standard grade Celecoxib API, Micronized Celecoxib API), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Celecoxib API.
Regionally, the report analyzes the Celecoxib API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Celecoxib API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Celecoxib API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Celecoxib API industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Standard grade Celecoxib API, Micronized Celecoxib API).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Celecoxib API market.
Regional Analysis: The report involves examining the Celecoxib API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Celecoxib API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Celecoxib API:
Company Analysis: Report covers individual Celecoxib API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Celecoxib API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Laboratory).
Technology Analysis: Report covers specific technologies relevant to Celecoxib API. It assesses the current state, advancements, and potential future developments in Celecoxib API areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Celecoxib API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Celecoxib API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Standard grade Celecoxib API
- Micronized Celecoxib API
- Pharmaceutical
- Laboratory
- Pfizer
- Teva Pharmaceuticals
- Viatris(Mylan)
- ScinoPharm
- Jiangxi Synergy
- Jiangsu Hengrui Medicine
- Jiangsu Chiatai Qingjiang
- Hisun Pharmaceutical Nantong
- Aurobindo Pharma
- Punjab Chemicals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Celecoxib API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celecoxib API, with price, sales, revenue and global market share of Celecoxib API from 2019 to 2024.
Chapter 3, the Celecoxib API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celecoxib API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Celecoxib API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celecoxib API.
Chapter 14 and 15, to describe Celecoxib API sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Celecoxib API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Celecoxib API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Standard grade Celecoxib API
1.3.3 Micronized Celecoxib API
1.4 Market Analysis by Application
1.4.1 Overview: Global Celecoxib API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical
1.4.3 Laboratory
1.5 Global Celecoxib API Market Size & Forecast
1.5.1 Global Celecoxib API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Celecoxib API Sales Quantity (2019-2030)
1.5.3 Global Celecoxib API Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Celecoxib API Product and Services
2.1.4 Pfizer Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business
2.2.3 Teva Pharmaceuticals Celecoxib API Product and Services
2.2.4 Teva Pharmaceuticals Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Teva Pharmaceuticals Recent Developments/Updates
2.3 Viatris(Mylan)
2.3.1 Viatris(Mylan) Details
2.3.2 Viatris(Mylan) Major Business
2.3.3 Viatris(Mylan) Celecoxib API Product and Services
2.3.4 Viatris(Mylan) Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Viatris(Mylan) Recent Developments/Updates
2.4 ScinoPharm
2.4.1 ScinoPharm Details
2.4.2 ScinoPharm Major Business
2.4.3 ScinoPharm Celecoxib API Product and Services
2.4.4 ScinoPharm Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ScinoPharm Recent Developments/Updates
2.5 Jiangxi Synergy
2.5.1 Jiangxi Synergy Details
2.5.2 Jiangxi Synergy Major Business
2.5.3 Jiangxi Synergy Celecoxib API Product and Services
2.5.4 Jiangxi Synergy Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Jiangxi Synergy Recent Developments/Updates
2.6 Jiangsu Hengrui Medicine
2.6.1 Jiangsu Hengrui Medicine Details
2.6.2 Jiangsu Hengrui Medicine Major Business
2.6.3 Jiangsu Hengrui Medicine Celecoxib API Product and Services
2.6.4 Jiangsu Hengrui Medicine Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.7 Jiangsu Chiatai Qingjiang
2.7.1 Jiangsu Chiatai Qingjiang Details
2.7.2 Jiangsu Chiatai Qingjiang Major Business
2.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product and Services
2.7.4 Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Jiangsu Chiatai Qingjiang Recent Developments/Updates
2.8 Hisun Pharmaceutical Nantong
2.8.1 Hisun Pharmaceutical Nantong Details
2.8.2 Hisun Pharmaceutical Nantong Major Business
2.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product and Services
2.8.4 Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hisun Pharmaceutical Nantong Recent Developments/Updates
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Celecoxib API Product and Services
2.9.4 Aurobindo Pharma Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Aurobindo Pharma Recent Developments/Updates
2.10 Punjab Chemicals
2.10.1 Punjab Chemicals Details
2.10.2 Punjab Chemicals Major Business
2.10.3 Punjab Chemicals Celecoxib API Product and Services
2.10.4 Punjab Chemicals Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Punjab Chemicals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CELECOXIB API BY MANUFACTURER
3.1 Global Celecoxib API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Celecoxib API Revenue by Manufacturer (2019-2024)
3.3 Global Celecoxib API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Celecoxib API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Celecoxib API Manufacturer Market Share in 2023
3.4.2 Top 6 Celecoxib API Manufacturer Market Share in 2023
3.5 Celecoxib API Market: Overall Company Footprint Analysis
3.5.1 Celecoxib API Market: Region Footprint
3.5.2 Celecoxib API Market: Company Product Type Footprint
3.5.3 Celecoxib API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Celecoxib API Market Size by Region
4.1.1 Global Celecoxib API Sales Quantity by Region (2019-2030)
4.1.2 Global Celecoxib API Consumption Value by Region (2019-2030)
4.1.3 Global Celecoxib API Average Price by Region (2019-2030)
4.2 North America Celecoxib API Consumption Value (2019-2030)
4.3 Europe Celecoxib API Consumption Value (2019-2030)
4.4 Asia-Pacific Celecoxib API Consumption Value (2019-2030)
4.5 South America Celecoxib API Consumption Value (2019-2030)
4.6 Middle East and Africa Celecoxib API Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Celecoxib API Sales Quantity by Type (2019-2030)
5.2 Global Celecoxib API Consumption Value by Type (2019-2030)
5.3 Global Celecoxib API Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Celecoxib API Sales Quantity by Application (2019-2030)
6.2 Global Celecoxib API Consumption Value by Application (2019-2030)
6.3 Global Celecoxib API Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Celecoxib API Sales Quantity by Type (2019-2030)
7.2 North America Celecoxib API Sales Quantity by Application (2019-2030)
7.3 North America Celecoxib API Market Size by Country
7.3.1 North America Celecoxib API Sales Quantity by Country (2019-2030)
7.3.2 North America Celecoxib API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Celecoxib API Sales Quantity by Type (2019-2030)
8.2 Europe Celecoxib API Sales Quantity by Application (2019-2030)
8.3 Europe Celecoxib API Market Size by Country
8.3.1 Europe Celecoxib API Sales Quantity by Country (2019-2030)
8.3.2 Europe Celecoxib API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Celecoxib API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Celecoxib API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Celecoxib API Market Size by Region
9.3.1 Asia-Pacific Celecoxib API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Celecoxib API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Celecoxib API Sales Quantity by Type (2019-2030)
10.2 South America Celecoxib API Sales Quantity by Application (2019-2030)
10.3 South America Celecoxib API Market Size by Country
10.3.1 South America Celecoxib API Sales Quantity by Country (2019-2030)
10.3.2 South America Celecoxib API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Celecoxib API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Celecoxib API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Celecoxib API Market Size by Country
11.3.1 Middle East & Africa Celecoxib API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Celecoxib API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Celecoxib API Market Drivers
12.2 Celecoxib API Market Restraints
12.3 Celecoxib API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Celecoxib API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Celecoxib API
13.3 Celecoxib API Production Process
13.4 Celecoxib API Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Celecoxib API Typical Distributors
14.3 Celecoxib API Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Celecoxib API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Celecoxib API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Standard grade Celecoxib API
1.3.3 Micronized Celecoxib API
1.4 Market Analysis by Application
1.4.1 Overview: Global Celecoxib API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical
1.4.3 Laboratory
1.5 Global Celecoxib API Market Size & Forecast
1.5.1 Global Celecoxib API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Celecoxib API Sales Quantity (2019-2030)
1.5.3 Global Celecoxib API Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Celecoxib API Product and Services
2.1.4 Pfizer Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business
2.2.3 Teva Pharmaceuticals Celecoxib API Product and Services
2.2.4 Teva Pharmaceuticals Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Teva Pharmaceuticals Recent Developments/Updates
2.3 Viatris(Mylan)
2.3.1 Viatris(Mylan) Details
2.3.2 Viatris(Mylan) Major Business
2.3.3 Viatris(Mylan) Celecoxib API Product and Services
2.3.4 Viatris(Mylan) Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Viatris(Mylan) Recent Developments/Updates
2.4 ScinoPharm
2.4.1 ScinoPharm Details
2.4.2 ScinoPharm Major Business
2.4.3 ScinoPharm Celecoxib API Product and Services
2.4.4 ScinoPharm Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ScinoPharm Recent Developments/Updates
2.5 Jiangxi Synergy
2.5.1 Jiangxi Synergy Details
2.5.2 Jiangxi Synergy Major Business
2.5.3 Jiangxi Synergy Celecoxib API Product and Services
2.5.4 Jiangxi Synergy Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Jiangxi Synergy Recent Developments/Updates
2.6 Jiangsu Hengrui Medicine
2.6.1 Jiangsu Hengrui Medicine Details
2.6.2 Jiangsu Hengrui Medicine Major Business
2.6.3 Jiangsu Hengrui Medicine Celecoxib API Product and Services
2.6.4 Jiangsu Hengrui Medicine Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.7 Jiangsu Chiatai Qingjiang
2.7.1 Jiangsu Chiatai Qingjiang Details
2.7.2 Jiangsu Chiatai Qingjiang Major Business
2.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product and Services
2.7.4 Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Jiangsu Chiatai Qingjiang Recent Developments/Updates
2.8 Hisun Pharmaceutical Nantong
2.8.1 Hisun Pharmaceutical Nantong Details
2.8.2 Hisun Pharmaceutical Nantong Major Business
2.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product and Services
2.8.4 Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hisun Pharmaceutical Nantong Recent Developments/Updates
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Celecoxib API Product and Services
2.9.4 Aurobindo Pharma Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Aurobindo Pharma Recent Developments/Updates
2.10 Punjab Chemicals
2.10.1 Punjab Chemicals Details
2.10.2 Punjab Chemicals Major Business
2.10.3 Punjab Chemicals Celecoxib API Product and Services
2.10.4 Punjab Chemicals Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Punjab Chemicals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CELECOXIB API BY MANUFACTURER
3.1 Global Celecoxib API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Celecoxib API Revenue by Manufacturer (2019-2024)
3.3 Global Celecoxib API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Celecoxib API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Celecoxib API Manufacturer Market Share in 2023
3.4.2 Top 6 Celecoxib API Manufacturer Market Share in 2023
3.5 Celecoxib API Market: Overall Company Footprint Analysis
3.5.1 Celecoxib API Market: Region Footprint
3.5.2 Celecoxib API Market: Company Product Type Footprint
3.5.3 Celecoxib API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Celecoxib API Market Size by Region
4.1.1 Global Celecoxib API Sales Quantity by Region (2019-2030)
4.1.2 Global Celecoxib API Consumption Value by Region (2019-2030)
4.1.3 Global Celecoxib API Average Price by Region (2019-2030)
4.2 North America Celecoxib API Consumption Value (2019-2030)
4.3 Europe Celecoxib API Consumption Value (2019-2030)
4.4 Asia-Pacific Celecoxib API Consumption Value (2019-2030)
4.5 South America Celecoxib API Consumption Value (2019-2030)
4.6 Middle East and Africa Celecoxib API Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Celecoxib API Sales Quantity by Type (2019-2030)
5.2 Global Celecoxib API Consumption Value by Type (2019-2030)
5.3 Global Celecoxib API Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Celecoxib API Sales Quantity by Application (2019-2030)
6.2 Global Celecoxib API Consumption Value by Application (2019-2030)
6.3 Global Celecoxib API Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Celecoxib API Sales Quantity by Type (2019-2030)
7.2 North America Celecoxib API Sales Quantity by Application (2019-2030)
7.3 North America Celecoxib API Market Size by Country
7.3.1 North America Celecoxib API Sales Quantity by Country (2019-2030)
7.3.2 North America Celecoxib API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Celecoxib API Sales Quantity by Type (2019-2030)
8.2 Europe Celecoxib API Sales Quantity by Application (2019-2030)
8.3 Europe Celecoxib API Market Size by Country
8.3.1 Europe Celecoxib API Sales Quantity by Country (2019-2030)
8.3.2 Europe Celecoxib API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Celecoxib API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Celecoxib API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Celecoxib API Market Size by Region
9.3.1 Asia-Pacific Celecoxib API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Celecoxib API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Celecoxib API Sales Quantity by Type (2019-2030)
10.2 South America Celecoxib API Sales Quantity by Application (2019-2030)
10.3 South America Celecoxib API Market Size by Country
10.3.1 South America Celecoxib API Sales Quantity by Country (2019-2030)
10.3.2 South America Celecoxib API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Celecoxib API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Celecoxib API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Celecoxib API Market Size by Country
11.3.1 Middle East & Africa Celecoxib API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Celecoxib API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Celecoxib API Market Drivers
12.2 Celecoxib API Market Restraints
12.3 Celecoxib API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Celecoxib API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Celecoxib API
13.3 Celecoxib API Production Process
13.4 Celecoxib API Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Celecoxib API Typical Distributors
14.3 Celecoxib API Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Celecoxib API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Celecoxib API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Celecoxib API Product and Services
Table 6. Pfizer Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Teva Pharmaceuticals Major Business
Table 10. Teva Pharmaceuticals Celecoxib API Product and Services
Table 11. Teva Pharmaceuticals Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Teva Pharmaceuticals Recent Developments/Updates
Table 13. Viatris(Mylan) Basic Information, Manufacturing Base and Competitors
Table 14. Viatris(Mylan) Major Business
Table 15. Viatris(Mylan) Celecoxib API Product and Services
Table 16. Viatris(Mylan) Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Viatris(Mylan) Recent Developments/Updates
Table 18. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 19. ScinoPharm Major Business
Table 20. ScinoPharm Celecoxib API Product and Services
Table 21. ScinoPharm Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. ScinoPharm Recent Developments/Updates
Table 23. Jiangxi Synergy Basic Information, Manufacturing Base and Competitors
Table 24. Jiangxi Synergy Major Business
Table 25. Jiangxi Synergy Celecoxib API Product and Services
Table 26. Jiangxi Synergy Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Jiangxi Synergy Recent Developments/Updates
Table 28. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 29. Jiangsu Hengrui Medicine Major Business
Table 30. Jiangsu Hengrui Medicine Celecoxib API Product and Services
Table 31. Jiangsu Hengrui Medicine Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 33. Jiangsu Chiatai Qingjiang Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Chiatai Qingjiang Major Business
Table 35. Jiangsu Chiatai Qingjiang Celecoxib API Product and Services
Table 36. Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Jiangsu Chiatai Qingjiang Recent Developments/Updates
Table 38. Hisun Pharmaceutical Nantong Basic Information, Manufacturing Base and Competitors
Table 39. Hisun Pharmaceutical Nantong Major Business
Table 40. Hisun Pharmaceutical Nantong Celecoxib API Product and Services
Table 41. Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Hisun Pharmaceutical Nantong Recent Developments/Updates
Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Aurobindo Pharma Major Business
Table 45. Aurobindo Pharma Celecoxib API Product and Services
Table 46. Aurobindo Pharma Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Aurobindo Pharma Recent Developments/Updates
Table 48. Punjab Chemicals Basic Information, Manufacturing Base and Competitors
Table 49. Punjab Chemicals Major Business
Table 50. Punjab Chemicals Celecoxib API Product and Services
Table 51. Punjab Chemicals Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Punjab Chemicals Recent Developments/Updates
Table 53. Global Celecoxib API Sales Quantity by Manufacturer (2019-2024) & (Kg)
Table 54. Global Celecoxib API Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Celecoxib API Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 56. Market Position of Manufacturers in Celecoxib API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Celecoxib API Production Site of Key Manufacturer
Table 58. Celecoxib API Market: Company Product Type Footprint
Table 59. Celecoxib API Market: Company Product Application Footprint
Table 60. Celecoxib API New Market Entrants and Barriers to Market Entry
Table 61. Celecoxib API Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Celecoxib API Sales Quantity by Region (2019-2024) & (Kg)
Table 63. Global Celecoxib API Sales Quantity by Region (2025-2030) & (Kg)
Table 64. Global Celecoxib API Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Celecoxib API Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Celecoxib API Average Price by Region (2019-2024) & (US$/Kg)
Table 67. Global Celecoxib API Average Price by Region (2025-2030) & (US$/Kg)
Table 68. Global Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 69. Global Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 70. Global Celecoxib API Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Celecoxib API Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Celecoxib API Average Price by Type (2019-2024) & (US$/Kg)
Table 73. Global Celecoxib API Average Price by Type (2025-2030) & (US$/Kg)
Table 74. Global Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 75. Global Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 76. Global Celecoxib API Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Celecoxib API Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Celecoxib API Average Price by Application (2019-2024) & (US$/Kg)
Table 79. Global Celecoxib API Average Price by Application (2025-2030) & (US$/Kg)
Table 80. North America Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 81. North America Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 82. North America Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 83. North America Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 84. North America Celecoxib API Sales Quantity by Country (2019-2024) & (Kg)
Table 85. North America Celecoxib API Sales Quantity by Country (2025-2030) & (Kg)
Table 86. North America Celecoxib API Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Celecoxib API Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 89. Europe Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 90. Europe Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 91. Europe Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 92. Europe Celecoxib API Sales Quantity by Country (2019-2024) & (Kg)
Table 93. Europe Celecoxib API Sales Quantity by Country (2025-2030) & (Kg)
Table 94. Europe Celecoxib API Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Celecoxib API Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 97. Asia-Pacific Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 98. Asia-Pacific Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 99. Asia-Pacific Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 100. Asia-Pacific Celecoxib API Sales Quantity by Region (2019-2024) & (Kg)
Table 101. Asia-Pacific Celecoxib API Sales Quantity by Region (2025-2030) & (Kg)
Table 102. Asia-Pacific Celecoxib API Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Celecoxib API Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 105. South America Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 106. South America Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 107. South America Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 108. South America Celecoxib API Sales Quantity by Country (2019-2024) & (Kg)
Table 109. South America Celecoxib API Sales Quantity by Country (2025-2030) & (Kg)
Table 110. South America Celecoxib API Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Celecoxib API Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 113. Middle East & Africa Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 114. Middle East & Africa Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 115. Middle East & Africa Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 116. Middle East & Africa Celecoxib API Sales Quantity by Region (2019-2024) & (Kg)
Table 117. Middle East & Africa Celecoxib API Sales Quantity by Region (2025-2030) & (Kg)
Table 118. Middle East & Africa Celecoxib API Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Celecoxib API Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Celecoxib API Raw Material
Table 121. Key Manufacturers of Celecoxib API Raw Materials
Table 122. Celecoxib API Typical Distributors
Table 123. Celecoxib API Typical Customers
Table 1. Global Celecoxib API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Celecoxib API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Celecoxib API Product and Services
Table 6. Pfizer Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Teva Pharmaceuticals Major Business
Table 10. Teva Pharmaceuticals Celecoxib API Product and Services
Table 11. Teva Pharmaceuticals Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Teva Pharmaceuticals Recent Developments/Updates
Table 13. Viatris(Mylan) Basic Information, Manufacturing Base and Competitors
Table 14. Viatris(Mylan) Major Business
Table 15. Viatris(Mylan) Celecoxib API Product and Services
Table 16. Viatris(Mylan) Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Viatris(Mylan) Recent Developments/Updates
Table 18. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 19. ScinoPharm Major Business
Table 20. ScinoPharm Celecoxib API Product and Services
Table 21. ScinoPharm Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. ScinoPharm Recent Developments/Updates
Table 23. Jiangxi Synergy Basic Information, Manufacturing Base and Competitors
Table 24. Jiangxi Synergy Major Business
Table 25. Jiangxi Synergy Celecoxib API Product and Services
Table 26. Jiangxi Synergy Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Jiangxi Synergy Recent Developments/Updates
Table 28. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 29. Jiangsu Hengrui Medicine Major Business
Table 30. Jiangsu Hengrui Medicine Celecoxib API Product and Services
Table 31. Jiangsu Hengrui Medicine Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 33. Jiangsu Chiatai Qingjiang Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Chiatai Qingjiang Major Business
Table 35. Jiangsu Chiatai Qingjiang Celecoxib API Product and Services
Table 36. Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Jiangsu Chiatai Qingjiang Recent Developments/Updates
Table 38. Hisun Pharmaceutical Nantong Basic Information, Manufacturing Base and Competitors
Table 39. Hisun Pharmaceutical Nantong Major Business
Table 40. Hisun Pharmaceutical Nantong Celecoxib API Product and Services
Table 41. Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Hisun Pharmaceutical Nantong Recent Developments/Updates
Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Aurobindo Pharma Major Business
Table 45. Aurobindo Pharma Celecoxib API Product and Services
Table 46. Aurobindo Pharma Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Aurobindo Pharma Recent Developments/Updates
Table 48. Punjab Chemicals Basic Information, Manufacturing Base and Competitors
Table 49. Punjab Chemicals Major Business
Table 50. Punjab Chemicals Celecoxib API Product and Services
Table 51. Punjab Chemicals Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Punjab Chemicals Recent Developments/Updates
Table 53. Global Celecoxib API Sales Quantity by Manufacturer (2019-2024) & (Kg)
Table 54. Global Celecoxib API Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Celecoxib API Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 56. Market Position of Manufacturers in Celecoxib API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Celecoxib API Production Site of Key Manufacturer
Table 58. Celecoxib API Market: Company Product Type Footprint
Table 59. Celecoxib API Market: Company Product Application Footprint
Table 60. Celecoxib API New Market Entrants and Barriers to Market Entry
Table 61. Celecoxib API Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Celecoxib API Sales Quantity by Region (2019-2024) & (Kg)
Table 63. Global Celecoxib API Sales Quantity by Region (2025-2030) & (Kg)
Table 64. Global Celecoxib API Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Celecoxib API Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Celecoxib API Average Price by Region (2019-2024) & (US$/Kg)
Table 67. Global Celecoxib API Average Price by Region (2025-2030) & (US$/Kg)
Table 68. Global Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 69. Global Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 70. Global Celecoxib API Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Celecoxib API Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Celecoxib API Average Price by Type (2019-2024) & (US$/Kg)
Table 73. Global Celecoxib API Average Price by Type (2025-2030) & (US$/Kg)
Table 74. Global Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 75. Global Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 76. Global Celecoxib API Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Celecoxib API Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Celecoxib API Average Price by Application (2019-2024) & (US$/Kg)
Table 79. Global Celecoxib API Average Price by Application (2025-2030) & (US$/Kg)
Table 80. North America Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 81. North America Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 82. North America Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 83. North America Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 84. North America Celecoxib API Sales Quantity by Country (2019-2024) & (Kg)
Table 85. North America Celecoxib API Sales Quantity by Country (2025-2030) & (Kg)
Table 86. North America Celecoxib API Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Celecoxib API Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 89. Europe Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 90. Europe Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 91. Europe Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 92. Europe Celecoxib API Sales Quantity by Country (2019-2024) & (Kg)
Table 93. Europe Celecoxib API Sales Quantity by Country (2025-2030) & (Kg)
Table 94. Europe Celecoxib API Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Celecoxib API Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 97. Asia-Pacific Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 98. Asia-Pacific Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 99. Asia-Pacific Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 100. Asia-Pacific Celecoxib API Sales Quantity by Region (2019-2024) & (Kg)
Table 101. Asia-Pacific Celecoxib API Sales Quantity by Region (2025-2030) & (Kg)
Table 102. Asia-Pacific Celecoxib API Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Celecoxib API Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 105. South America Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 106. South America Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 107. South America Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 108. South America Celecoxib API Sales Quantity by Country (2019-2024) & (Kg)
Table 109. South America Celecoxib API Sales Quantity by Country (2025-2030) & (Kg)
Table 110. South America Celecoxib API Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Celecoxib API Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Celecoxib API Sales Quantity by Type (2019-2024) & (Kg)
Table 113. Middle East & Africa Celecoxib API Sales Quantity by Type (2025-2030) & (Kg)
Table 114. Middle East & Africa Celecoxib API Sales Quantity by Application (2019-2024) & (Kg)
Table 115. Middle East & Africa Celecoxib API Sales Quantity by Application (2025-2030) & (Kg)
Table 116. Middle East & Africa Celecoxib API Sales Quantity by Region (2019-2024) & (Kg)
Table 117. Middle East & Africa Celecoxib API Sales Quantity by Region (2025-2030) & (Kg)
Table 118. Middle East & Africa Celecoxib API Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Celecoxib API Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Celecoxib API Raw Material
Table 121. Key Manufacturers of Celecoxib API Raw Materials
Table 122. Celecoxib API Typical Distributors
Table 123. Celecoxib API Typical Customers
LIST OF FIGURES
Figure 1. Celecoxib API Picture
Figure 2. Global Celecoxib API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Celecoxib API Consumption Value Market Share by Type in 2023
Figure 4. Standard grade Celecoxib API Examples
Figure 5. Micronized Celecoxib API Examples
Figure 6. Global Celecoxib API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Celecoxib API Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical Examples
Figure 9. Laboratory Examples
Figure 10. Global Celecoxib API Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Celecoxib API Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Celecoxib API Sales Quantity (2019-2030) & (Kg)
Figure 13. Global Celecoxib API Average Price (2019-2030) & (US$/Kg)
Figure 14. Global Celecoxib API Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Celecoxib API Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Celecoxib API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Celecoxib API Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Celecoxib API Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Celecoxib API Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Celecoxib API Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Celecoxib API Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Celecoxib API Average Price by Type (2019-2030) & (US$/Kg)
Figure 29. Global Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Celecoxib API Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Celecoxib API Average Price by Application (2019-2030) & (US$/Kg)
Figure 32. North America Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Celecoxib API Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Celecoxib API Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Celecoxib API Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Celecoxib API Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Celecoxib API Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Celecoxib API Consumption Value Market Share by Region (2019-2030)
Figure 52. China Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Celecoxib API Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Celecoxib API Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Celecoxib API Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Celecoxib API Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Celecoxib API Market Drivers
Figure 73. Celecoxib API Market Restraints
Figure 74. Celecoxib API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Celecoxib API in 2023
Figure 77. Manufacturing Process Analysis of Celecoxib API
Figure 78. Celecoxib API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Celecoxib API Picture
Figure 2. Global Celecoxib API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Celecoxib API Consumption Value Market Share by Type in 2023
Figure 4. Standard grade Celecoxib API Examples
Figure 5. Micronized Celecoxib API Examples
Figure 6. Global Celecoxib API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Celecoxib API Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical Examples
Figure 9. Laboratory Examples
Figure 10. Global Celecoxib API Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Celecoxib API Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Celecoxib API Sales Quantity (2019-2030) & (Kg)
Figure 13. Global Celecoxib API Average Price (2019-2030) & (US$/Kg)
Figure 14. Global Celecoxib API Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Celecoxib API Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Celecoxib API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Celecoxib API Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Celecoxib API Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Celecoxib API Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Celecoxib API Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Celecoxib API Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Celecoxib API Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Celecoxib API Average Price by Type (2019-2030) & (US$/Kg)
Figure 29. Global Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Celecoxib API Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Celecoxib API Average Price by Application (2019-2030) & (US$/Kg)
Figure 32. North America Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Celecoxib API Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Celecoxib API Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Celecoxib API Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Celecoxib API Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Celecoxib API Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Celecoxib API Consumption Value Market Share by Region (2019-2030)
Figure 52. China Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Celecoxib API Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Celecoxib API Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Celecoxib API Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Celecoxib API Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Celecoxib API Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Celecoxib API Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Celecoxib API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Celecoxib API Market Drivers
Figure 73. Celecoxib API Market Restraints
Figure 74. Celecoxib API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Celecoxib API in 2023
Figure 77. Manufacturing Process Analysis of Celecoxib API
Figure 78. Celecoxib API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
